These success, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the concept of focusing on ACKR3 as a novel method to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Diseases. A investigation review printed https://shintaros714kji6.ktwiki.com/user